These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26562011)

  • 1. Interferon-γ Inhibits Ebola Virus Infection.
    Rhein BA; Powers LS; Rogers K; Anantpadma M; Singh BK; Sakurai Y; Bair T; Miller-Hunt C; Sinn P; Davey RA; Monick MM; Maury W
    PLoS Pathog; 2015; 11(11):e1005263. PubMed ID: 26562011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
    Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
    Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.
    Barrientos LG; O'Keefe BR; Bray M; Sanchez A; Gronenborn AM; Boyd MR
    Antiviral Res; 2003 Mar; 58(1):47-56. PubMed ID: 12719006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.
    Qiu X; Kroeker A; He S; Kozak R; Audet J; Mbikay M; Chrétien M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5182-8. PubMed ID: 27297486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line.
    Aguilar-Briseño JA; Elliff JM; Patten JJ; Wilson LR; Davey RA; Bailey AL; Maury WJ
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Plasmodium Infection Promotes Interferon-Gamma-Dependent Resistance to Ebola Virus Infection.
    Rogers KJ; Shtanko O; Vijay R; Mallinger LN; Joyner CJ; Galinski MR; Butler NS; Maury W
    Cell Rep; 2020 Mar; 30(12):4041-4051.e4. PubMed ID: 32209467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
    PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.
    Chiramel AI; Banadyga L; Dougherty JD; Falzarano D; Martellaro C; Brees D; Taylor RT; Ebihara H; Best SM
    J Infect Dis; 2016 Oct; 214(suppl 3):S355-S359. PubMed ID: 27511894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
    Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.
    Harcourt BH; Sanchez A; Offermann MK
    J Virol; 1999 Apr; 73(4):3491-6. PubMed ID: 10074208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.